Related references
Note: Only part of the references are listed.Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany
N. Zander et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Psychosocial burden and out-of-pocket costs in patients with atopic dermatitis in Ireland
G. Murray et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population
N. Zander et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation
M. Augustin et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada
M. de Bruin-Weller et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Severe atopic dermatitis: Dupilumab is not just safer, but more efficient
Mara Giavina-Bianchi et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2020)
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
Lotte S. Spekhorst et al.
ALLERGY (2020)
The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis
Tatjana Honstein et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience
Silvia Ferrucci et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)
Diamant Thaci et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2019)
Importance of out-of-pocket costs for adult patients with atopic dermatitis in France
R. Launois et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Comorbidities and the impact of atopic dermatitis
Jonathan I. Silverberg
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
A critical appraisal and implications of the new National Institute for Health and Care Excellence guideline on dupilumab for treating moderate-to-severe atopic eczema
S. Weidinger et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD)
Wenhui Wei et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Review of health economic analyses in atopic dermatitis: how diverse is the literature?
Mandy Gutknecht et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries
Alexander Zink et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Cost-of-illness of psoriasis - results of a German cross-sectional study
D. Jungen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
The impact of atopic dermatitis on work life - a systematic review
L. B. Norreslet et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Epidemiology of atopic dermatitis in adults: Results from an international survey
S. Barbarot et al.
ALLERGY (2018)
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial
L. A. A. Gerbens et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Epidemiology of adult atopic dermatitis
Ryan Sacotte et al.
CLINICS IN DERMATOLOGY (2018)
Dupilumab: A review of its use in the treatment of atopic dermatitis
Melinda J. Gooderham et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Dupilumab for treatment of atopic dermatitis
Marlene Seegraeber et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Prevalence and comorbidities in adults with psoriasis compared to atopic eczema
M. A. Radtke et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases
Sulena Shrestha et al.
ADVANCES IN THERAPY (2017)
Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials
Eric L. Simpson
DERMATOLOGY AND THERAPY (2017)
Atopic Dermatitis: Global Epidemiology and Risk Factors
Sophie Nutten
ANNALS OF NUTRITION AND METABOLISM (2015)
Therapeutic Benefits in Atopic Dermatitis Care from the Patients' Perspective: Results of the German National Health Care Study 'Atopic Health'
Sabine Steinke et al.
DERMATOLOGY (2014)
Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth
A. Langenbruch et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Medizinische Versorgung und gesundheitsökonomische Relevanz der Neurodermitis
J. Schmitt
ALLERGOLOGIE (2011)
German recommendations on health economic evaluation - Third and updated version of the Hanover Consensus
J. -M. Graf von der Schulenburg et al.
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT (2007)
Patient perspectives on the management of atopic dermatitis
Torsten Zuberbier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Cost-of-illness study in patients suffering from atopic eczema in Germany
B Ehlken et al.
HAUTARZT (2005)
The costs of atopy and asthma in children: Assessment of direct costs and their determinants in a birth cohort
S Weinmann et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2003)
Share Paper
